Clinical implications of determination of plasma haloperidol levels

Acta Psychiatrica Scandinavica

Volumn 79, Issue 4, 1989, Pages 348-354

  Santos, J L ^a   Cabranes, J A ^a   Almoguera, I ^a   Ramos, J A ^b   Vazquez, C ^b   Angeles, F ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

haloperidol; schizophrenia

Indexed keywords

HALOPERIDOL;

ADULT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA;

ADULT; HALOPERIDOL; HUMAN; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0024536664     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1989.tb10269.x     Document Type: Article

References (38)

1. Relationship of serum haloperidol levels to clinical response in schizophrenic patients
2. Haloperidol levels and clinical response in schizophrenia
3. RBC and plasma levels of haloperidol and clinical response in schizophrenia
4. Haloperidol. Plasma levels and prolactin response as predictor of clinical improvement in schizophrenia: chemical and radioreceptor plasma level assay
5. Haloperidol and thioridazine levels and clinical response in schizophrenia: comparison of gas‐liquid chromatography and radioreceptor drug level assays
6. Clinical response and plasma haloperidol levels in schizophrenia
7. Does a therapeutic window for plasma haloperidol exist? Preliminary Chinese data
8. Haloperidol levels and clinical response: basic concepts and clinical data
9. Monitorización de los niveles plasmáticos de haloperidol en la esquizofrenia: utilidad clinica
10. Radioreceptor ensayo: un metodo sensible en la evaluacion de neurolepticos en plasma
11. High‐dosage haloperidol therapy in chronic schizophrenic patients: a double‐blind study of clinical response, side effects, serum haloperidol and serum prolactin
12. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed‐dose study
13. Haloperidol levels and clinical antipsychotic response
14. Gas chromatographic method for determining haloperidol
15. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat
16. Gas chromatographic electron impact and chemical ionization mass spectrometer of haloperidol and its chlorinated homologue
17. A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood
18. Radioimmunoassay of haloperidol in human serum
19. Radioimmunoassay of bomperidol and haloperidol in human and canine plasma
20. Serum haloperidol determinations psychiatric patients. Comparison of methods, correlation with serum prolactin levels
21. Plasma levels of chlorpromazine in schizophrenia: a critical review of literature
22. Plasma levels of neuroleptics, prolactin levels and clinical response
23. Molecular pathology receptors of schizophrenia: more than one disease process
24. The Brief Psychiatric Rating Scale
25. Rating scales in the measurement of change
26. Fluphenazine pharmacokinetics and clinical response
27. Clinical relevance of thiothixene plasma levels
28. Plasma haloperidol levels and clinical response: confounding variables
29. Respuesta clinica y niveles plasmaticos de haloperidol en esquizofrenicos cronicos y sub‐cronicos
30. Serum haloperidol concentrations and clinical response in acute psychosis
31. Differential effects of amphetamine and neuroleptics on negative vs positive symptoms in schizophrenia
32. Implications of normal brain development for the pathogenesis of schizophrenia
33. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
34. Monitoring of haloperidol serum levels: its clinical significance
35. Applied pharmacokinetics of haloperidol in man